Lee Scott Golden - 24 Nov 2025 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol
CVKD
Transactions as of
24 Nov 2025
Net transactions value
$0
Form type
3
Filing time
03 Dec 2025, 20:07:37 UTC
Previous filing
04 Apr 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Golden Lee Scott Director C/O CADRENAL THERAPEUTICS, INC.,, 822 A1A NORTH, SUITE 306, PONTE VEDRA /s/ Matthew K. Szot, Attorney-in-fact 03 Dec 2025 0001686217

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVKD Common Stock 1,667 24 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24- Power of Attorney